nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—CYP1A2—Pentoxifylline—systemic scleroderma	0.291	0.512	CbGbCtD
Thiabendazole—CYP1A2—Leflunomide—systemic scleroderma	0.277	0.488	CbGbCtD
Thiabendazole—Erythema multiforme—Captopril—systemic scleroderma	0.00239	0.00552	CcSEcCtD
Thiabendazole—Confusional state—Pentoxifylline—systemic scleroderma	0.00238	0.00552	CcSEcCtD
Thiabendazole—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00236	0.00547	CcSEcCtD
Thiabendazole—Hyperglycaemia—Leflunomide—systemic scleroderma	0.00234	0.00542	CcSEcCtD
Thiabendazole—Flushing—Captopril—systemic scleroderma	0.00234	0.00542	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.0023	0.00531	CcSEcCtD
Thiabendazole—Angioedema—Mometasone—systemic scleroderma	0.00228	0.00529	CcSEcCtD
Thiabendazole—Jaundice—Leflunomide—systemic scleroderma	0.00226	0.00522	CcSEcCtD
Thiabendazole—Anorexia—Pentoxifylline—systemic scleroderma	0.00225	0.00522	CcSEcCtD
Thiabendazole—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.00224	0.00517	CcSEcCtD
Thiabendazole—Hypotension—Pentoxifylline—systemic scleroderma	0.00221	0.00511	CcSEcCtD
Thiabendazole—Haematuria—Leflunomide—systemic scleroderma	0.00221	0.00511	CcSEcCtD
Thiabendazole—Jaundice—Mycophenolic acid—systemic scleroderma	0.00215	0.00498	CcSEcCtD
Thiabendazole—Haematuria—Mycophenolic acid—systemic scleroderma	0.00211	0.00488	CcSEcCtD
Thiabendazole—Somnolence—Pentoxifylline—systemic scleroderma	0.0021	0.00487	CcSEcCtD
Thiabendazole—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00208	0.00482	CcSEcCtD
Thiabendazole—Erythema multiforme—Azathioprine—systemic scleroderma	0.00208	0.00482	CcSEcCtD
Thiabendazole—Vision blurred—Captopril—systemic scleroderma	0.00207	0.00479	CcSEcCtD
Thiabendazole—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00206	0.00476	CcSEcCtD
Thiabendazole—Anaphylactic shock—Mometasone—systemic scleroderma	0.00204	0.00472	CcSEcCtD
Thiabendazole—Hyperglycaemia—Lisinopril—systemic scleroderma	0.00201	0.00466	CcSEcCtD
Thiabendazole—Angioedema—Captopril—systemic scleroderma	0.00201	0.00464	CcSEcCtD
Thiabendazole—Chills—Azathioprine—systemic scleroderma	0.00198	0.00457	CcSEcCtD
Thiabendazole—Hypoaesthesia—Mycophenolic acid—systemic scleroderma	0.00197	0.00457	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.00197	0.00457	CcSEcCtD
Thiabendazole—Erythema multiforme—Leflunomide—systemic scleroderma	0.00197	0.00455	CcSEcCtD
Thiabendazole—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00195	0.00451	CcSEcCtD
Thiabendazole—Anorexia—Mometasone—systemic scleroderma	0.00195	0.0045	CcSEcCtD
Thiabendazole—Jaundice—Lisinopril—systemic scleroderma	0.00194	0.00449	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00193	0.00448	CcSEcCtD
Thiabendazole—Visual impairment—Mycophenolic acid—systemic scleroderma	0.00191	0.00442	CcSEcCtD
Thiabendazole—Haematuria—Lisinopril—systemic scleroderma	0.0019	0.00439	CcSEcCtD
Thiabendazole—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00187	0.00433	CcSEcCtD
Thiabendazole—Chills—Leflunomide—systemic scleroderma	0.00187	0.00432	CcSEcCtD
Thiabendazole—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00185	0.00428	CcSEcCtD
Thiabendazole—Confusional state—Captopril—systemic scleroderma	0.00181	0.00418	CcSEcCtD
Thiabendazole—Dyspepsia—Mometasone—systemic scleroderma	0.0018	0.00416	CcSEcCtD
Thiabendazole—Anaphylactic shock—Captopril—systemic scleroderma	0.00179	0.00415	CcSEcCtD
Thiabendazole—Chills—Mycophenolic acid—systemic scleroderma	0.00178	0.00412	CcSEcCtD
Thiabendazole—Decreased appetite—Mometasone—systemic scleroderma	0.00177	0.00411	CcSEcCtD
Thiabendazole—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00176	0.00408	CcSEcCtD
Thiabendazole—Fatigue—Mometasone—systemic scleroderma	0.00176	0.00407	CcSEcCtD
Thiabendazole—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00174	0.00403	CcSEcCtD
Thiabendazole—Leukopenia—Azathioprine—systemic scleroderma	0.00172	0.00397	CcSEcCtD
Thiabendazole—Anorexia—Captopril—systemic scleroderma	0.00171	0.00395	CcSEcCtD
Thiabendazole—Vision blurred—Leflunomide—systemic scleroderma	0.00171	0.00395	CcSEcCtD
Thiabendazole—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.0017	0.00393	CcSEcCtD
Thiabendazole—Asthenia—Pentoxifylline—systemic scleroderma	0.0017	0.00393	CcSEcCtD
Thiabendazole—Erythema multiforme—Lisinopril—systemic scleroderma	0.00169	0.00391	CcSEcCtD
Thiabendazole—Hypotension—Captopril—systemic scleroderma	0.00167	0.00388	CcSEcCtD
Thiabendazole—Pruritus—Pentoxifylline—systemic scleroderma	0.00167	0.00387	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00167	0.00386	CcSEcCtD
Thiabendazole—Tinnitus—Lisinopril—systemic scleroderma	0.00167	0.00385	CcSEcCtD
Thiabendazole—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00385	CcSEcCtD
Thiabendazole—Flushing—Lisinopril—systemic scleroderma	0.00166	0.00384	CcSEcCtD
Thiabendazole—Angioedema—Leflunomide—systemic scleroderma	0.00165	0.00383	CcSEcCtD
Thiabendazole—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00163	0.00377	CcSEcCtD
Thiabendazole—Leukopenia—Leflunomide—systemic scleroderma	0.00162	0.00375	CcSEcCtD
Thiabendazole—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00162	0.00374	CcSEcCtD
Thiabendazole—Abdominal pain—Mometasone—systemic scleroderma	0.00161	0.00373	CcSEcCtD
Thiabendazole—Chills—Lisinopril—systemic scleroderma	0.0016	0.00371	CcSEcCtD
Thiabendazole—Somnolence—Captopril—systemic scleroderma	0.00159	0.00369	CcSEcCtD
Thiabendazole—Dyspepsia—Captopril—systemic scleroderma	0.00158	0.00365	CcSEcCtD
Thiabendazole—Dizziness—Pentoxifylline—systemic scleroderma	0.00156	0.00362	CcSEcCtD
Thiabendazole—Decreased appetite—Captopril—systemic scleroderma	0.00156	0.00361	CcSEcCtD
Thiabendazole—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.00156	0.0036	CcSEcCtD
Thiabendazole—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00155	0.00358	CcSEcCtD
Thiabendazole—Fatigue—Captopril—systemic scleroderma	0.00155	0.00358	CcSEcCtD
Thiabendazole—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00349	CcSEcCtD
Thiabendazole—Vomiting—Pentoxifylline—systemic scleroderma	0.0015	0.00348	CcSEcCtD
Thiabendazole—Lymphadenopathy—Methotrexate—systemic scleroderma	0.0015	0.00348	CcSEcCtD
Thiabendazole—Convulsion—Mycophenolic acid—systemic scleroderma	0.0015	0.00346	CcSEcCtD
Thiabendazole—Rash—Pentoxifylline—systemic scleroderma	0.00149	0.00345	CcSEcCtD
Thiabendazole—Dermatitis—Pentoxifylline—systemic scleroderma	0.00149	0.00345	CcSEcCtD
Thiabendazole—Headache—Pentoxifylline—systemic scleroderma	0.00148	0.00343	CcSEcCtD
Thiabendazole—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00148	0.00342	CcSEcCtD
Thiabendazole—Feeling abnormal—Captopril—systemic scleroderma	0.00148	0.00342	CcSEcCtD
Thiabendazole—Vision blurred—Lisinopril—systemic scleroderma	0.00147	0.00339	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Captopril—systemic scleroderma	0.00147	0.00339	CcSEcCtD
Thiabendazole—Asthenia—Mometasone—systemic scleroderma	0.00146	0.00339	CcSEcCtD
Thiabendazole—Hypotension—Azathioprine—systemic scleroderma	0.00146	0.00338	CcSEcCtD
Thiabendazole—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00338	CcSEcCtD
Thiabendazole—Pruritus—Mometasone—systemic scleroderma	0.00144	0.00334	CcSEcCtD
Thiabendazole—Hepatic failure—Methotrexate—systemic scleroderma	0.00143	0.0033	CcSEcCtD
Thiabendazole—Angioedema—Lisinopril—systemic scleroderma	0.00142	0.00329	CcSEcCtD
Thiabendazole—Confusional state—Mycophenolic acid—systemic scleroderma	0.00142	0.00329	CcSEcCtD
Thiabendazole—Abdominal pain—Captopril—systemic scleroderma	0.00142	0.00328	CcSEcCtD
Thiabendazole—Anorexia—Leflunomide—systemic scleroderma	0.00141	0.00326	CcSEcCtD
Thiabendazole—Nausea—Pentoxifylline—systemic scleroderma	0.0014	0.00325	CcSEcCtD
Thiabendazole—Chills—Mycophenolate mofetil—systemic scleroderma	0.0014	0.00325	CcSEcCtD
Thiabendazole—Diarrhoea—Mometasone—systemic scleroderma	0.0014	0.00323	CcSEcCtD
Thiabendazole—Leukopenia—Lisinopril—systemic scleroderma	0.00139	0.00322	CcSEcCtD
Thiabendazole—Hypotension—Leflunomide—systemic scleroderma	0.00138	0.00319	CcSEcCtD
Thiabendazole—Anorexia—Mycophenolic acid—systemic scleroderma	0.00134	0.00311	CcSEcCtD
Thiabendazole—Hypotension—Mycophenolic acid—systemic scleroderma	0.00132	0.00305	CcSEcCtD
Thiabendazole—Dyspepsia—Leflunomide—systemic scleroderma	0.0013	0.00301	CcSEcCtD
Thiabendazole—Vomiting—Mometasone—systemic scleroderma	0.0013	0.003	CcSEcCtD
Thiabendazole—Feeling abnormal—Azathioprine—systemic scleroderma	0.00129	0.00298	CcSEcCtD
Thiabendazole—Rash—Mometasone—systemic scleroderma	0.00129	0.00298	CcSEcCtD
Thiabendazole—Asthenia—Captopril—systemic scleroderma	0.00129	0.00298	CcSEcCtD
Thiabendazole—Dermatitis—Mometasone—systemic scleroderma	0.00129	0.00297	CcSEcCtD
Thiabendazole—Decreased appetite—Leflunomide—systemic scleroderma	0.00128	0.00297	CcSEcCtD
Thiabendazole—Confusional state—Lisinopril—systemic scleroderma	0.00128	0.00296	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00128	0.00296	CcSEcCtD
Thiabendazole—Headache—Mometasone—systemic scleroderma	0.00128	0.00296	CcSEcCtD
Thiabendazole—Fatigue—Leflunomide—systemic scleroderma	0.00127	0.00295	CcSEcCtD
Thiabendazole—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00127	0.00294	CcSEcCtD
Thiabendazole—Pruritus—Captopril—systemic scleroderma	0.00127	0.00293	CcSEcCtD
Thiabendazole—Somnolence—Mycophenolic acid—systemic scleroderma	0.00125	0.0029	CcSEcCtD
Thiabendazole—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00288	CcSEcCtD
Thiabendazole—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00124	0.00287	CcSEcCtD
Thiabendazole—Abdominal pain—Azathioprine—systemic scleroderma	0.00124	0.00286	CcSEcCtD
Thiabendazole—Diarrhoea—Captopril—systemic scleroderma	0.00123	0.00284	CcSEcCtD
Thiabendazole—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00122	0.00283	CcSEcCtD
Thiabendazole—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00282	CcSEcCtD
Thiabendazole—Feeling abnormal—Leflunomide—systemic scleroderma	0.00122	0.00282	CcSEcCtD
Thiabendazole—Fatigue—Mycophenolic acid—systemic scleroderma	0.00121	0.00281	CcSEcCtD
Thiabendazole—Nausea—Mometasone—systemic scleroderma	0.00121	0.00281	CcSEcCtD
Thiabendazole—Anorexia—Lisinopril—systemic scleroderma	0.00121	0.0028	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00121	0.0028	CcSEcCtD
Thiabendazole—Hyperglycaemia—Prednisone—systemic scleroderma	0.0012	0.00277	CcSEcCtD
Thiabendazole—Hypotension—Lisinopril—systemic scleroderma	0.00119	0.00274	CcSEcCtD
Thiabendazole—Dizziness—Captopril—systemic scleroderma	0.00119	0.00274	CcSEcCtD
Thiabendazole—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00273	CcSEcCtD
Thiabendazole—Abdominal pain—Leflunomide—systemic scleroderma	0.00117	0.0027	CcSEcCtD
Thiabendazole—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00116	0.00269	CcSEcCtD
Thiabendazole—Hypersensitivity—Azathioprine—systemic scleroderma	0.00115	0.00267	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00115	0.00267	CcSEcCtD
Thiabendazole—Vomiting—Captopril—systemic scleroderma	0.00114	0.00264	CcSEcCtD
Thiabendazole—Rash—Captopril—systemic scleroderma	0.00113	0.00262	CcSEcCtD
Thiabendazole—Dermatitis—Captopril—systemic scleroderma	0.00113	0.00261	CcSEcCtD
Thiabendazole—Somnolence—Lisinopril—systemic scleroderma	0.00113	0.00261	CcSEcCtD
Thiabendazole—Headache—Captopril—systemic scleroderma	0.00112	0.0026	CcSEcCtD
Thiabendazole—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00112	0.0026	CcSEcCtD
Thiabendazole—Dyspepsia—Lisinopril—systemic scleroderma	0.00112	0.00259	CcSEcCtD
Thiabendazole—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00111	0.00258	CcSEcCtD
Thiabendazole—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00257	CcSEcCtD
Thiabendazole—Decreased appetite—Lisinopril—systemic scleroderma	0.0011	0.00255	CcSEcCtD
Thiabendazole—Fatigue—Lisinopril—systemic scleroderma	0.00109	0.00253	CcSEcCtD
Thiabendazole—Hypersensitivity—Leflunomide—systemic scleroderma	0.00109	0.00252	CcSEcCtD
Thiabendazole—Diarrhoea—Azathioprine—systemic scleroderma	0.00107	0.00248	CcSEcCtD
Thiabendazole—Nausea—Captopril—systemic scleroderma	0.00106	0.00246	CcSEcCtD
Thiabendazole—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00245	CcSEcCtD
Thiabendazole—Asthenia—Leflunomide—systemic scleroderma	0.00106	0.00245	CcSEcCtD
Thiabendazole—Feeling abnormal—Lisinopril—systemic scleroderma	0.00105	0.00242	CcSEcCtD
Thiabendazole—Pruritus—Leflunomide—systemic scleroderma	0.00105	0.00242	CcSEcCtD
Thiabendazole—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00104	0.0024	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00104	0.0024	CcSEcCtD
Thiabendazole—Dizziness—Azathioprine—systemic scleroderma	0.00103	0.00239	CcSEcCtD
Thiabendazole—Asthenia—Mycophenolic acid—systemic scleroderma	0.00101	0.00234	CcSEcCtD
Thiabendazole—Diarrhoea—Leflunomide—systemic scleroderma	0.00101	0.00234	CcSEcCtD
Thiabendazole—Abdominal pain—Lisinopril—systemic scleroderma	0.001	0.00232	CcSEcCtD
Thiabendazole—Pruritus—Mycophenolic acid—systemic scleroderma	0.000997	0.00231	CcSEcCtD
Thiabendazole—Vomiting—Azathioprine—systemic scleroderma	0.000994	0.0023	CcSEcCtD
Thiabendazole—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000989	0.00229	CcSEcCtD
Thiabendazole—Drowsiness—Methotrexate—systemic scleroderma	0.000988	0.00229	CcSEcCtD
Thiabendazole—Rash—Azathioprine—systemic scleroderma	0.000986	0.00228	CcSEcCtD
Thiabendazole—Dermatitis—Azathioprine—systemic scleroderma	0.000985	0.00228	CcSEcCtD
Thiabendazole—Flushing—Prednisone—systemic scleroderma	0.000985	0.00228	CcSEcCtD
Thiabendazole—Headache—Azathioprine—systemic scleroderma	0.00098	0.00227	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000979	0.00227	CcSEcCtD
Thiabendazole—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000979	0.00227	CcSEcCtD
Thiabendazole—Dizziness—Leflunomide—systemic scleroderma	0.000977	0.00226	CcSEcCtD
Thiabendazole—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000967	0.00224	CcSEcCtD
Thiabendazole—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000964	0.00223	CcSEcCtD
Thiabendazole—Haematuria—Methotrexate—systemic scleroderma	0.000942	0.00218	CcSEcCtD
Thiabendazole—Vomiting—Leflunomide—systemic scleroderma	0.000939	0.00217	CcSEcCtD
Thiabendazole—Hypersensitivity—Lisinopril—systemic scleroderma	0.000935	0.00216	CcSEcCtD
Thiabendazole—Dizziness—Mycophenolic acid—systemic scleroderma	0.000932	0.00216	CcSEcCtD
Thiabendazole—Rash—Leflunomide—systemic scleroderma	0.000931	0.00216	CcSEcCtD
Thiabendazole—Dermatitis—Leflunomide—systemic scleroderma	0.00093	0.00215	CcSEcCtD
Thiabendazole—Nausea—Azathioprine—systemic scleroderma	0.000929	0.00215	CcSEcCtD
Thiabendazole—Headache—Leflunomide—systemic scleroderma	0.000925	0.00214	CcSEcCtD
Thiabendazole—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000916	0.00212	CcSEcCtD
Thiabendazole—Asthenia—Lisinopril—systemic scleroderma	0.000911	0.00211	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000909	0.0021	CcSEcCtD
Thiabendazole—Pruritus—Lisinopril—systemic scleroderma	0.000898	0.00208	CcSEcCtD
Thiabendazole—Vomiting—Mycophenolic acid—systemic scleroderma	0.000896	0.00207	CcSEcCtD
Thiabendazole—Rash—Mycophenolic acid—systemic scleroderma	0.000888	0.00206	CcSEcCtD
Thiabendazole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000888	0.00205	CcSEcCtD
Thiabendazole—Headache—Mycophenolic acid—systemic scleroderma	0.000883	0.00204	CcSEcCtD
Thiabendazole—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000879	0.00203	CcSEcCtD
Thiabendazole—Nausea—Leflunomide—systemic scleroderma	0.000877	0.00203	CcSEcCtD
Thiabendazole—Vision blurred—Prednisone—systemic scleroderma	0.00087	0.00201	CcSEcCtD
Thiabendazole—Diarrhoea—Lisinopril—systemic scleroderma	0.000868	0.00201	CcSEcCtD
Thiabendazole—Visual impairment—Methotrexate—systemic scleroderma	0.000855	0.00198	CcSEcCtD
Thiabendazole—Angioedema—Prednisone—systemic scleroderma	0.000844	0.00195	CcSEcCtD
Thiabendazole—Dizziness—Lisinopril—systemic scleroderma	0.000839	0.00194	CcSEcCtD
Thiabendazole—Erythema multiforme—Methotrexate—systemic scleroderma	0.000838	0.00194	CcSEcCtD
Thiabendazole—Nausea—Mycophenolic acid—systemic scleroderma	0.000837	0.00194	CcSEcCtD
Thiabendazole—Tinnitus—Methotrexate—systemic scleroderma	0.000827	0.00191	CcSEcCtD
Thiabendazole—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000819	0.0019	CcSEcCtD
Thiabendazole—Vomiting—Lisinopril—systemic scleroderma	0.000807	0.00187	CcSEcCtD
Thiabendazole—Rash—Lisinopril—systemic scleroderma	0.0008	0.00185	CcSEcCtD
Thiabendazole—Convulsion—Prednisone—systemic scleroderma	0.0008	0.00185	CcSEcCtD
Thiabendazole—Dermatitis—Lisinopril—systemic scleroderma	0.0008	0.00185	CcSEcCtD
Thiabendazole—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000798	0.00185	CcSEcCtD
Thiabendazole—Chills—Methotrexate—systemic scleroderma	0.000796	0.00184	CcSEcCtD
Thiabendazole—Headache—Lisinopril—systemic scleroderma	0.000795	0.00184	CcSEcCtD
Thiabendazole—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000787	0.00182	CcSEcCtD
Thiabendazole—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000761	0.00176	CcSEcCtD
Thiabendazole—Nausea—Lisinopril—systemic scleroderma	0.000754	0.00174	CcSEcCtD
Thiabendazole—Anaphylactic shock—Prednisone—systemic scleroderma	0.000754	0.00174	CcSEcCtD
Thiabendazole—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000735	0.0017	CcSEcCtD
Thiabendazole—Vision blurred—Methotrexate—systemic scleroderma	0.000727	0.00168	CcSEcCtD
Thiabendazole—Anorexia—Prednisone—systemic scleroderma	0.000719	0.00166	CcSEcCtD
Thiabendazole—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000707	0.00164	CcSEcCtD
Thiabendazole—Rash—Mycophenolate mofetil—systemic scleroderma	0.000701	0.00162	CcSEcCtD
Thiabendazole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000701	0.00162	CcSEcCtD
Thiabendazole—Headache—Mycophenolate mofetil—systemic scleroderma	0.000697	0.00161	CcSEcCtD
Thiabendazole—Leukopenia—Methotrexate—systemic scleroderma	0.000691	0.0016	CcSEcCtD
Thiabendazole—Convulsion—Methotrexate—systemic scleroderma	0.000669	0.00155	CcSEcCtD
Thiabendazole—Dyspepsia—Prednisone—systemic scleroderma	0.000664	0.00154	CcSEcCtD
Thiabendazole—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000661	0.00153	CcSEcCtD
Thiabendazole—Decreased appetite—Prednisone—systemic scleroderma	0.000655	0.00152	CcSEcCtD
Thiabendazole—Fatigue—Prednisone—systemic scleroderma	0.00065	0.0015	CcSEcCtD
Thiabendazole—Confusional state—Methotrexate—systemic scleroderma	0.000635	0.00147	CcSEcCtD
Thiabendazole—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00063	0.00146	CcSEcCtD
Thiabendazole—Feeling abnormal—Prednisone—systemic scleroderma	0.000621	0.00144	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000616	0.00143	CcSEcCtD
Thiabendazole—Anorexia—Methotrexate—systemic scleroderma	0.0006	0.00139	CcSEcCtD
Thiabendazole—Abdominal pain—Prednisone—systemic scleroderma	0.000596	0.00138	CcSEcCtD
Thiabendazole—Hypotension—Methotrexate—systemic scleroderma	0.000589	0.00136	CcSEcCtD
Thiabendazole—Somnolence—Methotrexate—systemic scleroderma	0.00056	0.0013	CcSEcCtD
Thiabendazole—Hypersensitivity—Prednisone—systemic scleroderma	0.000555	0.00129	CcSEcCtD
Thiabendazole—Dyspepsia—Methotrexate—systemic scleroderma	0.000555	0.00128	CcSEcCtD
Thiabendazole—Decreased appetite—Methotrexate—systemic scleroderma	0.000548	0.00127	CcSEcCtD
Thiabendazole—Fatigue—Methotrexate—systemic scleroderma	0.000543	0.00126	CcSEcCtD
Thiabendazole—Asthenia—Prednisone—systemic scleroderma	0.000541	0.00125	CcSEcCtD
Thiabendazole—Pruritus—Prednisone—systemic scleroderma	0.000533	0.00123	CcSEcCtD
Thiabendazole—Feeling abnormal—Methotrexate—systemic scleroderma	0.000519	0.0012	CcSEcCtD
Thiabendazole—Diarrhoea—Prednisone—systemic scleroderma	0.000516	0.00119	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000515	0.00119	CcSEcCtD
Thiabendazole—Dizziness—Prednisone—systemic scleroderma	0.000498	0.00115	CcSEcCtD
Thiabendazole—Abdominal pain—Methotrexate—systemic scleroderma	0.000498	0.00115	CcSEcCtD
Thiabendazole—Vomiting—Prednisone—systemic scleroderma	0.000479	0.00111	CcSEcCtD
Thiabendazole—Rash—Prednisone—systemic scleroderma	0.000475	0.0011	CcSEcCtD
Thiabendazole—Dermatitis—Prednisone—systemic scleroderma	0.000475	0.0011	CcSEcCtD
Thiabendazole—Headache—Prednisone—systemic scleroderma	0.000472	0.00109	CcSEcCtD
Thiabendazole—Hypersensitivity—Methotrexate—systemic scleroderma	0.000464	0.00107	CcSEcCtD
Thiabendazole—Asthenia—Methotrexate—systemic scleroderma	0.000452	0.00105	CcSEcCtD
Thiabendazole—Nausea—Prednisone—systemic scleroderma	0.000448	0.00104	CcSEcCtD
Thiabendazole—Pruritus—Methotrexate—systemic scleroderma	0.000446	0.00103	CcSEcCtD
Thiabendazole—Diarrhoea—Methotrexate—systemic scleroderma	0.000431	0.000998	CcSEcCtD
Thiabendazole—Dizziness—Methotrexate—systemic scleroderma	0.000417	0.000964	CcSEcCtD
Thiabendazole—Vomiting—Methotrexate—systemic scleroderma	0.000401	0.000927	CcSEcCtD
Thiabendazole—Rash—Methotrexate—systemic scleroderma	0.000397	0.000919	CcSEcCtD
Thiabendazole—Dermatitis—Methotrexate—systemic scleroderma	0.000397	0.000918	CcSEcCtD
Thiabendazole—Headache—Methotrexate—systemic scleroderma	0.000395	0.000913	CcSEcCtD
Thiabendazole—Nausea—Methotrexate—systemic scleroderma	0.000374	0.000866	CcSEcCtD
